Kush Parmar insider trades
Open-market stock purchases and sales by Kush Parmar, Unknown at Entrada Therapeutics, Inc, from SEC Form 4 filings since Aug 24, 2016.
Track record: 25% of 4 scored buys are up 5% or more since purchase, averaging -24%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 10, 2026 | TRDA Entrada Therapeutics, Inc | Sold | $647K |
| Aug 7, 2026 | TRDA Entrada Therapeutics, Inc | Sold | $358K |
| Aug 6, 2026 | TRDA Entrada Therapeutics, Inc | Sold | $73.5K |
| Jul 31, 2026 | TRDA Entrada Therapeutics, Inc | Sold | $11.8K |
| Jul 30, 2026 | TRDA Entrada Therapeutics, Inc | Sold | $795K |
| Jun 10, 2026 | TRDA Entrada Therapeutics, Inc | Bought (not open market) | — |
| Nov 14, 2025 | TRDA Entrada Therapeutics, Inc | Sold | $1.8M |
Companies traded
- TRDA Entrada Therapeutics, Inc: 1 buy, 14 sales, last Aug 10, 2026
- RLYB Rallybio Corp: 1 buy, 7 sales, last May 15, 2024
- AKUS Akouos, Inc: 1 buy, 2 sales, last Dec 1, 2022
- FIXX Homology Medicines, Inc: 14 sales, last Jun 15, 2022
- VOR Vor Biopharma Inc: 2 buys, 2 sales, last Jun 14, 2022
- (TRDA Entrada Therapeutics, Inc: other filings, last Oct 28, 2021
- FVAM 5:01 Acquisition Corp: other filings, last Nov 30, 2020
- ARVN Arvinas, Inc: other filings, last Sep 24, 2019
- SCPH scPharmaceuticals Inc: other filings, last Jun 19, 2018
- BOLD Audentes Therapeutics, Inc: other filings, last Jun 8, 2018